BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6611230)

  • 1. Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.
    Emery P; Panayi GS; Nouri AM
    Clin Exp Immunol; 1984 Jul; 57(1):123-9. PubMed ID: 6611230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte function in anergic patients.
    Rode HN; Christou NV; Bubenik O; Superina R; Gordon J; Meakins JL; MacLean LD
    Clin Exp Immunol; 1982 Jan; 47(1):155-61. PubMed ID: 6212172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformation.
    Simmler MC; Rameau G; Chou MJ; Mathé G
    Isr J Med Sci; 1976; 12(4-5):472-8. PubMed ID: 939695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro effects of gold salts on lymphocyte transformation responses and antibody dependent cell-mediated cytotoxicity.
    Davis P; Percy JS; Russell AS
    J Rheumatol; 1979; 6(5):527-33. PubMed ID: 118255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro cell-mediated immunity in tuberculous meningitis.
    El-Naggar AK; Higashi GI
    J Clin Lab Immunol; 1982 May; 8(1):37-42. PubMed ID: 7047745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies.
    Boras Z; Juretić A; Rudolf M; Uzarević B; Trescec A
    Croat Med J; 2002 Jun; 43(3):301-5. PubMed ID: 12035136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of HLA-DR4 to defective cellular immunity in rheumatoid arthritis using PPD, and mycoplasma and lectin mitogens.
    Emery P; Panayi GS; Welsh KI; Cole BC
    J Rheumatol; 1985 Oct; 12(5):859-64. PubMed ID: 3878876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin.
    Goodwin JS; Bankhurst AD; Murphy SA; Selinger DS; Messner RP; Williams RC
    J Clin Lab Immunol; 1978 Nov; 1(3):197-9. PubMed ID: 756469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of exogenous interleukin 1 and interleukin 2 to correct decreased lymphocyte transformation in chronic hepatitis B virus carriers.
    Anastassakos C; Alexander GJ; Wolstencroft RA; Dumonde DC; Eddleston AL; Williams R
    Clin Exp Immunol; 1987 Apr; 68(1):15-22. PubMed ID: 2958184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced in vitro tuberculin reactivity of lymphocytes from patients with tuberculosis.
    Onwubalili JK
    J Clin Lab Immunol; 1987 Oct; 24(2):81-5. PubMed ID: 3437441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pregnancy serum inhibits interleukin-2 production.
    Nicholas NS; Panayi GS; Nouri AM
    Clin Exp Immunol; 1984 Dec; 58(3):587-95. PubMed ID: 6239719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal lymphocyte reactivity to self-major histocompatibility antigens in rheumatoid arthritis.
    Kingsley GH; Pitzalis C; Panayi GS
    J Rheumatol; 1987 Aug; 14(4):667-73. PubMed ID: 2959772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity in sarcoidosis: effect of corticosteroids.
    Gross NJ; Holt PJ
    Br J Dis Chest; 1977 Jan; 71(1):25-34. PubMed ID: 318850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of human lymphocyte proliferative response to purified protein derivative by an anti-interleukin-2 receptor alpha chain antibody (CD25).
    Kasinrerk W; Majdic O; Praputpittaya K; Sittisombut N
    Immunology; 1994 Sep; 83(1):33-7. PubMed ID: 7821963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell mediated immunity in rheumatoid arthritis: Imparied lymphocyte responsiveness, humoral immunosuppressants, and correlations with clinical status in patients off drug therapy.
    Lloyd TM; Panush RS
    J Rheumatol; 1977; 4(3):231-44. PubMed ID: 926101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of cellular immunity in patients with rheumatoid arthritis by phytohaemagglutinin skin test.
    Kaćaki J; Budimir M; Berović Z
    Rheumatology; 1975; 6():72-9. PubMed ID: 1202609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological aspects of Mycobacterium avium complex infection].
    Tsuyuguchi I
    Kekkaku; 1993 Jan; 68(1):71-8. PubMed ID: 8437428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous delayed hypersensitivity, T cell subsets, and IL-2 secretion in patients with peripheral vascular disease.
    Ulrich F; Johnson WC; Rudders RA
    J Clin Lab Immunol; 1985 Nov; 18(3):107-12. PubMed ID: 3878884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of lymphocytes of patients with rheumatoid arthritis to IgG modified by oxygen radicals or peroxynitrite.
    Grinnell S; Yoshida K; Jasin HE
    Arthritis Rheum; 2005 Jan; 52(1):80-3. PubMed ID: 15641043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responses.
    Kirkham BW; Corkill MM; Davison SC; Panayi GS
    J Rheumatol; 1991 Jun; 18(6):821-5. PubMed ID: 1895263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.